---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-050433"
form_type: "8-K"
ticker: "FENC"
cik: "0001211583"
company_name: "FENNEC PHARMACEUTICALS INC."
filed_at: "2026-04-28T23:59:59+00:00"
generated_at: "2026-05-15T02:44:05.483934+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Fennec board member Raykov retiring; board reduced to 5 directors

## Summary
- Rostislav Raykov notified company on Apr 27, 2026, of retirement from Board.
- Will not stand for re-election at 2026 annual meeting; term ends after meeting.
- Departure not due to any disagreement with company on operations or policies.
- Board size reduced from 6 to 5 directors effective after annual meeting.
- No board vacancies expected following the meeting and Raykov's departure.

## SEC filing metadata
- accession: 0001104659-26-050433
- form_type: 8-K
- ticker: FENC
- cik: 0001211583
- company_name: FENNEC PHARMACEUTICALS INC.
- filed_at: 2026-04-28T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1211583/000110465926050433/0001104659-26-050433-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1211583/000110465926050433/fencf-20260427x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-050433
- JSON: https://secwatch.observer/filing/0001104659-26-050433.json
- Plain text: https://secwatch.observer/filing/0001104659-26-050433.txt

## Key facts
- Executive change
  Rostislav Raykov departed as Board member at FENNEC PHARMACEUTICALS INC..
  - Action: retire
  - Role: Board member
  source text: On April 27, 2026, Rostislav Raykov notified Fennec Pharmaceuticals Inc. (the "Company") of his desire to retire from the Company's Board of Directors (the "Board") and that he will not stand for re-election at the Company's 2026 annual meeting of shareholders (the "Annual Meeting").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1211583/000110465926050433/0001104659-26-050433-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.